Equipping you to understand more about personalised cancer care and its potential within your community, and engage with policy makers to support greater use of personalised care  

The Personalised Cancer Care Toolkit was created on the basis of the Personalised Healthcare Hub and Toolkit for the Patient Community and was co-created with patient leaders. It includes a suite of educational resources on the topic of personalised cancer care and its benefits for people and communities affected by cancer.

The toolkit is for patient advocacy groups, patient leaders, people living with cancer and caregivers. The resources have been created in a variety of formats so you can use them in different situations, such as meeting and event presentations, handouts and as conversation starters.

To increase understanding of personalised healthcare and its potential to benefit people affected by health conditions, you can share the Personalised Cancer Care Toolkit, the Personalised Healthcare Toolkit for the Patient Community and the Personalised Healthcare Hub, with members of your community. You can find guidance on how to share here.

Personalised Cancer Care Toolkit

The materials below have been adapted under Creative Commons licensing so they are most relevant to you and your community’s needs.

For patient advocacy groups and patient leaders

Core slide deck

An overview of the challenges and opportunities of implementing personalised cancer care. 

For people living with cancer, their caregivers and policy makers

Factsheets

To help support an understanding of the principles of personalised care in specific cancer types, with a focus on the importance of biomarker testing and the benefits this can bring to the cancer community and society.

Infographics

Outlining the principles of personalised care in cancer, with a focus on the importance of biomarker testing and the benefits this can bring to the cancer community and society.

Guide to medical terms

A glossary of key terms used in personalised cancer care, as well as specific examples of biomarkers for certain cancer types (e.g. lung cancer).